NASDAQ: ADVM       Adverum Biotechnlgs
Last Price Today's Change   Day's Range   Trading Volume
20.48   +0.02 (0.10%)  20.20 - 21.36  600,500


Avg Volume (4 weeks):1,380,390
4 Weeks Range:18.66 - 26.98
4 Weeks Price Volatility (%):
52 Weeks Range:4.96 - 26.98
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Adverum Biotechnologies Inc is a US-based clinical-stage gene therapy company. The company is committed to discovering and developing novel medicines that can offer potentially life-changing therapeutic benefit to patients living with rare diseases or diseases of the eye, who currently have limited or burdensome treatment options. Its services are focused on advancing three lead gene therapy programs to address unmet needs in wet age-related macular degeneration and in rare diseases alpha-1 antitrypsin deficiency and hereditary angioedema. Its leading programs include ADVM-022, ADVM-043 and ADVM-053.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

2695  5557  512  153 

Top 10 Active Counters
 NIO 13.22+1.71 
 TOPS 0.105-0.028 
 LK 1.38+1.38 
 GNUS 2.29-0.37 
 CRVS 4.95+2.21 
 SQQQ 6.73+0.11 
 SPY 313.78-3.27 
 AAL 11.92-0.88 
 ZOM 0.1720.00 
 UAVS 1.66+0.38 
Partners & Brokers